The limits on sales of Type 2 diabetes drugs tirzepatide and dulaglutide come after a 2023 regulation limited sales of semaglutide, which is sold under the band name Ozempic.
As case numbers rise, Ontario pharmacists can follow algorithm to assess patients and prescribe doxycycline to prevent Lyme disease after a high-risk tick bite.